Would "on ventilator" be considered extreme critic
Post# of 148280
Only ventilator free surely would make it easier for HGEN to reach their this "new" endpoint. But is not good that it was felt they needed to change the endpoint. However, who trusts anybody today with the amount of corruption. So now, HGEN reaches their endpoint and gets an EUA? Dr Patterson commented that the HGEN therapeutic would only have significant efficacy for about 20% of the s/c population.
I proposed this idea on a board somewhere. If a high % of folks on ventilators don't have much chance of living, maybe they should be excluded from trials. They just skew the results toward a worse p value.
Regardless, it did shake investor confidence.
At close HGEN was up 13%.
Then the news came out after market close.
Then down 16% in after market.
Tomorrow?
Could be a boost for Leronlimab. (Boost is lil bro to catalyst)